May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Impact of Benzalkonium Chloride (BAK) on the Mutant Prevention Concentrations (MPCs) of Gatifloxacin (Gfx) and Moxifloxacin (Mfx) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates
Author Affiliations & Notes
  • J. M. Blondeau
    Clinical Microbiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada
  • C. Hesje
    Clinical Microbiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada
  • Footnotes
    Commercial Relationships  J.M. Blondeau, Allergan, Alcon and Bausch & Lomb, C; C. Hesje, None.
  • Footnotes
    Support  Research grant in support of invitro susceptibility measurements
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1979. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. M. Blondeau, C. Hesje; Impact of Benzalkonium Chloride (BAK) on the Mutant Prevention Concentrations (MPCs) of Gatifloxacin (Gfx) and Moxifloxacin (Mfx) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates. Invest. Ophthalmol. Vis. Sci. 2008;49(13):1979. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the propensity of Gfx and Mfx to select for fluoroquinolone-resistant MRSA in the presence and absence of BAK. The MPC was defined as the antimicrobial drug concentration required to inhibit the growth of the least susceptible cell present in high-density bacterial populations.

Methods: : Nine clinical MRSA isolates and 1 methicillin-susceptible S aureus strain, ATCC 29213, were tested. MRSA were inoculated at the density of 1010 CFU/mL onto agar plates containing 2-fold concentration increments of either Gfx or Mfx alone or in combination with BAK at concentrations of 5 µg/mL or 7-10 µg/mL. Following incubation under ambient conditions, the lowest concentration(s) preventing growth was determined as the MPC.

Results: : The MPCs of Gfx and Mfx in the presence and absence of BAK against MRSA isolates and ATCC 29213 are presented in the table. The presence of BAK at concentrations from 7 µg/mL to 10 µg/mL lowered the MPCs of Gfx and Mfx against MRSA by 32- to 1000-fold. The MPCs of Gfx and Mfx in the presence of 5 µg/mL of BAK were less consistent.

Keywords: Staphylococcus • antibiotics/antifungals/antiparasitics • bacterial disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×